Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Bard Peripheral Vascular, Inc.

Approvalsdevice cleared14 Aug 2026

Bard Peripheral Vascular, Inc.

14 Aug 2026: Device cleared · EnCor EnCompass™ Breast Biopsy and Tissue Removal System. Recorded in the openFDA device 510(k) data.

View the source record

Decided
14 Aug 2026
Device
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
Specialty
Gastroenterology, Urology
Country
United States
Location
Tempe, AZ
Clearance type
Special
510(k) number
K262571
Submitted
2026-07-24
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Bard Peripheral Vascular, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Bard Peripheral Vascular, Inc. in our registers.

More in Gastroenterology, Urology

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.